Drug Discovery Informatics for Big Pharma: Key Webinar Insights
Collaborative Drug
MARCH 21, 2025
The pharmaceutical R&D landscape continues to evolve rapidly with advances in computational technologies and artificial intelligence.
Investors put $400M into biotech licensing obesity drugs from China
BioPharma Drive: Drug Pricing
MAY 16, 2024
The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.
Licensing 
356
356 Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology
BioPharma Drive: Drug Pricing
SEPTEMBER 4, 2024
But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. Over the past 10 years, PD1-blocking medicines have transformed cancer care.
ADHD Drug Zenzedi Recalled Over Pill Mixup
Drugs.com
JANUARY 30, 2024
30, 2024 -- The maker of a drug used to treat ADHD and narcolepsy has recalled one lot of the medication after a pill mixup was discovered.The recall notice, issued by Azurity Pharmaceuticals Inc., TUESDAY, Jan. states that one lot of Zenzedi.
Drugs 347
347 
Lilly weight loss drug approved by FDA
BioPharma Drive: Drug Pricing
NOVEMBER 8, 2023
The pharmaceutical company will sell the GLP-1 drug, branded as Zepbound, at a list price about 20% lower than Novo Nordisk's competing drug Wegovy.
How AI will reshape pharma by 2025
Drug Target Review
DECEMBER 20, 2024
Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.
Clinical Trials 128
128 
Real-world evidence in pharmaceutical drug development – faster, safer and more relevant?
BioPharma Drive: Drug Pricing
NOVEMBER 13, 2023
How can these increase the probability of success or efficiency in a pre-clinical and clinical drug development program? Regulatory agencies have set the framework and use cases for RWE.
Drug Development 274
274 
India’s Growing Importance in Generic Drug API Manufacturing
Drug Patent Watch
DECEMBER 10, 2024
India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.
Government 96
96 
Novo Nordisk To Pay $2 Billion for New Weight Loss Drug
Drugs.com
MARCH 25, 2025
TUESDAY, March 25, 2025 -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed.
Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures
Drug Patent Watch
DECEMBER 9, 2024
In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. What is a Drug Patent?
Drugs 96
96 
The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing
Drug Patent Watch
DECEMBER 10, 2024
The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48
Maker Is Pulling Controversial ALS Drug Relyvrio Off the Market
Drugs.com
APRIL 4, 2024
THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.
Marketing 279
279 
Poor Trial Results May Prompt Maker to Pull ALS Drug, Relyvrio, From Market
Drugs.com
MARCH 11, 2024
MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.
Marketing 289
289 
Genentech takes up a deal to make ‘molecular glue’ drugs
BioPharma Drive: Drug Pricing
SEPTEMBER 20, 2023
Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.
The Role of Artificial Intelligence (AI) and Machine Learning (ML) in Drug Repurposing
Drug Patent Watch
DECEMBER 3, 2024
In the ever-evolving landscape of pharmaceutical research and development, a revolutionary force is reshaping the way we approach drug discovery and repurposing. This force is none other than Artificial Intelligence (AI) and Machine Learning (ML).
Drugs 95
95 
A new, non-opioid pain drug is here. Getting it to patients could be agony.
BioPharma Drive: Drug Pricing
JANUARY 31, 2025
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
Pharmaceuticals 319
319 
Managing Drug Patent Portfolios Effectively
Drug Patent Watch
NOVEMBER 11, 2024
Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.
How to Develop a Sustainable Generic Drug Development Strategy
Drug Patent Watch
DECEMBER 11, 2024
The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. “Generics are known for their cost-effectiveness.
Lilly market value soars on higher sales, obesity drug potential
BioPharma Drive: Drug Pricing
AUGUST 8, 2023
The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.
Marketing 246
246 
How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing
Drug Patent Watch
DECEMBER 12, 2024
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.
Licensing 92
92 
Optimizing Generic Drug Development with Machine Learning
Drug Patent Watch
DECEMBER 4, 2024
The pharmaceutical industry is undergoing a significant transformation with the advent of machine learning methods. These methods have the potential to revolutionize the drug discovery process by enhancing the efficiency and accuracy of identifying and developing new drug candidates.
Pfizer wins FDA approval for its $7B colitis drug
BioPharma Drive: Drug Pricing
OCTOBER 13, 2023
Acquired with the buyout of Arena Pharmaceuticals, Velsipity enters a competitive market for ulcerative colitis pills.
FDA Approval 293
293 
Handling Drug Patent Abandonment: Opportunities and Challenges
Drug Patent Watch
OCTOBER 30, 2024
The pharmaceutical industry is known for its complex regulatory environment and lengthy product development processes. One often overlooked aspect of this industry is the potential benefits of abandoned and expired patents.
Pharmaceuticals 103
103 
Handling Drug Patent Invalidity Claims
Drug Patent Watch
DECEMBER 8, 2024
The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.
Biosimilars 98
98 
Lilly to buy injectable drug plant in manufacturing ramp-up
BioPharma Drive: Drug Pricing
APRIL 22, 2024
The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.
Pharmaceuticals 284
284 
Can drugs be blockbusters without relying on US sales?
Drug Patent Watch
NOVEMBER 18, 2024
The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S.
Drugs 98
98 
Lessons from Monte Carlo Models: Why Drug Development is Hard
DrugBaron
FEBRUARY 16, 2024
“There is more than one way to skin a cat” is a rather gruesome British idiom, but its sentiment surely applies to running a successful pharmaceutical portfolio. But not everyone in drug development is playing this game. No wonder investing in drug development is so hard! But how do you know which game you are playing?
Drug Development 355
355 
CDMO Selection: The Ultimate Checklist
Drug Patent Watch
DECEMBER 11, 2024
This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects. Your Drugs Development Stage The stage of your drug development is a critical factor in selecting a CDMO.
Managing Drug Patent Litigation Costs
Drug Patent Watch
MARCH 17, 2025
The Hidden Costs of Drug Patent Litigation: How to Stay Ahead of the Game As a pharmaceutical professional, you're no stranger to the complexities of drug patent litigation. In today's fast-paced pharmaceutical landscape, patent litigation is an inevitable reality. The stakes are high, and the costs can be astronomical.
Drugs 95
95 
FDA OKs Amvuttra To Treat Heart Conditions
Drugs.com
MARCH 24, 2025
Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to. MONDAY, March 24, 2025 -- The U.S.
FDA 276
276 
After surprise trial failure, ALS doctors brace for one less treatment option
BioPharma Drive: Drug Pricing
MARCH 12, 2024
Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.
Doctors 313
313 
Employers foresee higher health costs next year due to rising pharmacy spend
BioPharma Drive: Drug Pricing
AUGUST 21, 2024
Pharmaceuticals like the in-demand GLP-1 drugs for obesity are expected to drive increases in healthcare spending in 2025, per a new employer survey.
Pharmacy 284
284 
Redefining Acceleration of the Drug Development Journey
PPD
NOVEMBER 11, 2024
It is hard to ignore some of the most pressing, long-term trends driving the push to accelerate innovation and progress in drug development. As a result, biopharma and biotech companies working to bring their drug pipelines to the market require deep expertise from trusted partners to help deliver critical therapies for their patients.
When Do Drug Patents Expire: Understanding the Lifecycle of Pharmaceutical Innovations
Drug Patent Watch
OCTOBER 1, 2024
The answer often lies in the complex world of drug patents. Let’s dive into the fascinating realm of pharmaceutical intellectual property and explore when drug patents expire. Drug patents are a crucial aspect of the pharmaceutical industry. They provide companies with exclusive… Source
Pharmaceuticals 111
111 
New Drugs, Mounjaro, Orforglipron, and CagriSema Line Up to Challenge Ozempic, Wegovy for Weight Loss
Drugs.com
JUNE 26, 2023
MONDAY, June 26, 2023 -- After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed. Other pharmaceutical giants took notice,
Drugs 214
214 
Drafting Effective Drug Patent Applications: Turning Science into Market Power
Drug Patent Watch
APRIL 10, 2025
"Just spent the morning digging into the world of pharmaceuticals and I'm blown away by the complexities of drafting effective drug patent applications. The team at Drug Patent Watch has done an incredible job of breaking down the key considerations for turning scientific discoveries into market power.
Science 80
80 
Common Reasons for Drug Patent Rejections and Solutions
Drug Patent Watch
DECEMBER 3, 2024
The process of obtaining a patent for a drug invention can be complex and time-consuming. Despite the best efforts of inventors and patent attorneys, many drug patent applications are rejected by patent offices. When facing a rejection… Source
Drugs 96
96 
Experimental Pain Med Could Give Patients New Option to Opioids
Drugs.com
JANUARY 30, 2024
For now, the drug from Vertex Pharmaceuticals is called VX-548. TUESDAY, Jan. 30, 2024 -- The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.
Pharmaceuticals 297
297 
Top 10 CDMO Services You Didn’t Know You Needed
Drug Patent Watch
OCTOBER 28, 2024
The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. CDMOs provide a wide range of services that cater to the diverse needs of pharmaceutical companies, from early-stage development to commercial manufacturing.
FDA Approves First New Non-Opioid Pain Pill in Decades
Drugs.com
JANUARY 31, 2025
Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.The new pill, developed by Vertex Pharmaceuticals. FRIDAY, Jan. 31, 2025 -- The U.S.
FDA Approval 246
246 
Which pharmaceutical drugs have the most drug patents in Canada?
Drug Patent Watch
OCTOBER 20, 2023
This chart shows the drugs with the most patents in Canada. The post Which pharmaceutical drugs have the most drug patents in Canada? Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceuticals 105
105 
Which pharmaceutical companies have the most implant dosed drugs?
Drug Patent Watch
DECEMBER 5, 2023
This chart shows the pharmaceutical companies with the most implant dosed drugs. The companies with the most implant dosed drugs… The post Which pharmaceutical companies have the most implant dosed drugs? For a different perspective, see the most popular dosage types.
Which pharmaceutical drugs have the most drug patents in Israel?
Drug Patent Watch
SEPTEMBER 11, 2023
This chart shows the drugs with the most patents in Israel. The post Which pharmaceutical drugs have the most drug patents in Israel? Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceuticals 105
105 
Using Drug Patents to Block Competitors: The Tactics and Consequences
Drug Patent Watch
FEBRUARY 11, 2025
The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. What do you think?
Drugs 93
93 
Let's personalize your content